Harvard Bioscience Inc
$ 6.09
-0.49%
30 Jul - close price
- Market Cap 27,602,300 USD
- Current Price $ 6.09
- High / Low $ 6.19 / 5.98
- Stock P/E N/A
- Book Value 2.23
- EPS -2.18
- Next Earning Report 2026-08-10
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.02 %
- ROE -0.79 %
- 52 Week High 9.40
- 52 Week Low 3.75
About
Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enable fundamental research, discovery, and preclinical testing for drug development. The company is headquartered in Holliston, Massachusetts.
Analyst Target Price
$6.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-12 | 2026-03-12 | 2025-11-06 | 2025-08-11 | 2025-05-12 | 2025-03-12 | 2024-11-07 | 2024-08-08 | 2024-05-07 | 2024-03-07 | 2023-11-07 | 2023-08-08 |
| Reported EPS | -0.77 | -0.6383 | -0.03 | -0.1 | -0.1 | 0.04 | -0.2 | -0.0673 | 0.2 | 0.04 | 0.1 | 0.4 |
| Estimated EPS | -0.95 | 0.04 | 0.05 | -0.25 | -0.4 | 0.05 | 0.15 | 0.5 | 0.25 | 0.05 | 0.4 | 0.55 |
| Surprise | 0.18 | -0.6783 | -0.08 | 0.15 | 0.3 | -0.01 | -0.35 | -0.5673 | -0.05 | -0.01 | -0.3 | -0.15 |
| Surprise Percentage | 18.9474% | -1695.75% | -160% | 60% | 75% | -20% | -233.3333% | -113.46% | -20% | -20% | -75% | -27.2727% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-10 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | |
| Currency | USD |
Previous Dividend Records
| Jan 1970 | |
|---|---|
| Payment Date | None |
| Amount | $1.2832258065 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: HBIO
2026-07-28 23:12:27
Harvard Bioscience, Inc. (Nasdaq: HBIO) has announced it will release its second-quarter 2026 financial results before market open on August 11, 2026. A conference call to discuss these results will take place at 8:00 a.m. Eastern Time on the same day. Analysts R.S.V.P via a provided link, and an audio-only webcast will be available on the company’s investor website.
2026-07-28 23:12:27
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced it will release its financial results for the second quarter of 2026 on August 11, 2026, before market open. The company will also host a conference call at 8:00 a.m. Eastern Time on the same day to discuss these results. Analysts interested in participating in the Q&A session need to register, while an audio webcast will be available for other participants.
2026-07-28 13:09:27
Harvard Bioscience Inc (NASDAQ: HBIO) will release its second-quarter 2026 financial results before market open on August 11, 2026. The company will host a conference call on the same day at 8:00 AM ET to discuss its performance and business outlook. Financial materials, including the earnings release and slide presentations, will be available on the Investor Relations section of Harvard Bioscience’s website following the announcement.
2026-07-28 11:11:41
Harvard Bioscience, Inc. (Nasdaq: HBIO) announced it will release its second quarter 2026 financial results on August 11, 2026, before market open. The company will host a conference call to discuss these results at 8:00 AM Eastern Time on the same day. Analysts and participants can register for the call or access the audio-only webcast via the investor relations website.
2026-07-28 11:09:27
Harvard Bioscience (Nasdaq: HBIO) announced that it will release its financial results for the quarter ended June 30, 2026, before the market opens on August 11, 2026. The company will host an earnings conference call at 8:00 a.m. Eastern Time on the same day to discuss the results. Analysts and investors can register for the call or access a webcast via the company's investor relations website, where the earnings release and related materials will also be available.
2026-07-28 07:30:00
Harvard Bioscience, Inc. (Nasdaq: HBIO) will release its second quarter 2026 financial results on August 11, 2026, before market open. The company will host a conference call to discuss these results at 8:00 a.m. Eastern Time. Analysts and participants can register to join the call or access an audio-only webcast via the investor website.
